子宮内膜症治療市場規模、シェア、動向分析レポート：治療タイプ別、薬剤クラス別、投与経路別、流通チャネル別、地域別、セグメント予測、2025年～2030年

子宮内膜症治療市場の成長と動向

Grand View Research, Incの最新レポートによると、世界の子宮内膜症治療市場規模は、2025～2030年にかけて12.25％のCAGRを記録し、2030年までに35億2,000万米ドルに達する見込みです。

この市場成長の背景には、後期段階の強力な製品パイプラインの存在、世界の症例の急増、政府と主要企業が疾患に対する認識を高めるために国内外レベルで行っているいくつかの取り組みがあります。

宇宙における新たな治療オプションの研究開発の成長は、今後数年間の市場成長に有利な機会を提供すると予想されます。Myovant/PfizerのRelugolix配合錠、ObsEvaのYselty（リンザゴリックス）、Ferring Pharmaceuticals/NovartisのQuinagolideの発売は、この領域における著名な薬剤の発売の一つであり、市場の成長を促進すると予想されます。

子宮内膜症治療に対する需要の高まりは、疾病負担の増大と診断の遅れによる病状の悪化に起因しています。WHOによると、2021年3月には、女性の生殖人口の約10％がこの病気に罹患しています。子宮内膜症診断の遅れが医療資源利用とコストに与える影響」という紙製によると、最初の症状が出てから診断が3年以上遅れると、症状発現後早期に診断された患者と比較して、症状負担が増加し、医療費が50％増加するといいます。

WHO、各国政府、民間団体は、子宮内膜症やその治療に関する普及啓発に戦略的に取り組んでおり、市場の成長を支えています。例えば、2022年3月、Endometriosis Foundation of Americaは、患者や医師をフィーチャーしたバーチャルプログラムの4回の週末を開催し、子宮内膜症の戦士をつなぎ、この病気に関する経験を共有することに貢献しました。さらに、2022年3月には、英国子宮内膜症協会も「子宮内膜症アクション月間」に8項目のアクションプランを立ち上げました。

さらに、主要企業はM&A、提携、財政投資、地理的拡大などの戦略的イニシアチブをとっており、子宮内膜症治療市場を煽っています。例えば、2021年11月、Organon and Co.はForendo Pharmaの買収を発表し、Forendoの第2相臨床候補薬OR-6219のような子宮内膜症の新薬開発を支援します。

子宮内膜症治療市場レポートハイライト

• 治療タイプ別では、医師による配合率が高いホルモン療法が2024年の市場で最大シェアを占めます。
• ゴナドトロピン放出ホルモン（GnRH）セグメントは、GnRHアゴニストとGnRHアンタゴニストの高い有効性と市場におけるこれらの製品の入手可能性の増加により、2024年に薬剤クラス別セグメントを支配しました。
• 2024年の投与経路別シェアでは、経口剤が48.46％で市場を独占しました。経口投与は、同セグメントの大半の製品にとって最も一般的で利便性の高い投与経路です。
• 2024年には、流通チャネル別では小売薬局セグメントが市場を独占しました。また、病院薬局は緩やかな成長が見込まれます。
• 北米は2024年に世界市場を席巻したが、これは疾病罹患率の上昇と症状治療に対する人々や医療専門家の高い意識によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数と動向

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場動向と展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ビジネス環境分析
  • ポーターのファイブフォース分析
  • PESTEL分析
• パイプライン分析（フェーズ3）

第4章 子宮内膜症治療市場-治療タイプ別セグメント分析、2018～2030年

• 子宮内膜症治療市場：治療タイプの変動分析
• 治療タイプ別
  • 鎮痛薬
  • ホルモン療法

第5章 子宮内膜症治療市場-薬剤クラス別セグメント分析、2018～2030年

• 子宮内膜症治療市場：薬剤クラスの変動分析
• 薬剤クラス別
  • NSAID
  • 経口避妊薬
  • ゴナドトロピン放出ホルモン
  • その他

第6章 子宮内膜症治療市場-投与経路別セグメント分析、2018～2030年

• 子宮内膜症治療市場：投与経路の変動分析
• 投与経路別
  • 経口
  • 注射
  • その他

第7章 子宮内膜症治療市場-流通チャネル別セグメント分析、2018～2030年

• 子宮内膜症治療市場：流通チャネルの変動分析
• 流通チャネル別
  • 病院薬局
  • 小売薬局
  • その他

第8章 子宮内膜症治療市場：タイプ、薬剤クラス、投与経路、流通チャネルによる地域別、推定・動向分析

• 子宮内膜症治療市場：地域別展望
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 参入企業
• Participants'Overviews
• 企業の市況分析
• 企業プロファイル
  • Bayer AG
  • Pfizer, Inc.
  • AbbVie, Inc
  • AstraZeneca
  • ObsEva SA
  • Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • ELI LILLY AND COMPANY
  • Astellas Pharma, Inc.
• 戦略マッピング
  • 新製品の発売
  • 取得
  • コラボレーション
  • パートナーシップ
  • その他（臨床検査、キャンペーン、法律、価格設定）

第10章 結論

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviation
• Table 3 List of Parameters
• Table 4 List of Distributors
• Table 5 Global Endometriosis Treatment Market, By Region, 2018 - 2030 (USD Million)
• Table 6 Global Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 7 Global Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 8 Global Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 9 Global Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 10 North America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 11 North America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 12 North America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 13 North America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 14 North America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 15 U.S. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 16 U.S. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 17 U.S. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 18 U.S. Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 19 Canada Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 20 Canada Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 21 Canada Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 22 Canada Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 23 Mexico Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 24 Mexico Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 25 Mexico Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 26 Mexico Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 27 Mexico Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 28 Europe Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 29 Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 30 Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 31 Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 32 Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 33 Germany Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 34 Germany Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 35 Germany Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 36 Germany Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 37 UK Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 38 UK Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 39 UK Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 40 UK Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 41 France Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 42 France Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 43 France Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 44 France Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 45 Italy Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 46 Italy Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 47 Italy Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 48 Italy Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 49 Spain Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 50 Spain Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 51 Spain Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 52 Spain Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 53 Denmark Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 54 Denmark Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 55 Denmark Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 56 Denmark Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 57 Sweden Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 58 Sweden Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 59 Sweden Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 60 Sweden Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 61 Norway Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 62 Norway Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 63 Norway Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 64 Norway Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 65 Rest of Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 66 Rest of Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 67 Rest of Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 68 Rest of Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 69 Asia Pacific Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 70 Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 71 Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 72 Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 73 Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 74 Japan Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 75 Japan Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 76 Japan Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 77 Japan Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 78 China Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 79 China Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 80 China Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 81 China Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 82 India Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 83 India Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 84 India Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 85 India Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 86 South Korea Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 87 South Korea Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 88 South Korea Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 89 South Korea Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 90 Australia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 91 Australia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 92 Australia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 93 Australia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 94 Thailand Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 95 Thailand Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 96 Thailand Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 97 Thailand Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 98 Rest of Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 99 Rest of Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 100 Rest of Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 101 Rest of Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 102 Latin America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 103 Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 104 Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 105 Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 106 Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 107 Brazil Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 108 Brazil Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 109 Brazil Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 110 Brazil Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 111 Mexico Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 112 Mexico Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 113 Mexico Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 114 Mexico Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 115 Argentina Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 116 Argentina Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 117 Argentina Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 118 Argentina Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 119 Rest of Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 120 Rest of Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 121 Rest of Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 122 Rest of Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 123 Middle East & Africa Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 124 Middle East & Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 125 Middle East & Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 126 Middle East & Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 127 Middle East & Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 128 Saudi Arabia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 129 Saudi Arabia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 130 Saudi Arabia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 131 Saudi Arabia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 132 South Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 133 South Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 134 South Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 135 South Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 136 UAE Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 137 UAE Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 138 UAE Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 139 UAE Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 140 Kuwait Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 141 Kuwait Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 142 Kuwait Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 143 Kuwait Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 144 Rest of MEA Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 145 Rest of MEA Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 146 Rest of MEA Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 147 Rest of MEA Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 148 Key companies undergoing new product launches
• Table 149 Key companies undergoing new acquisitions
• Table 150 Key companies undergoing collaborations
• Table 151 Key companies undergoing partnerships
• Table 152 Key companies undergoing other strategies

List of Figures

• Fig. 1 Endometriosis treatment market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Value chain based sizing & forecasting
• Fig. 6 QFD modelling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Treatment type and drug class segment snapshot
• Fig. 10 Route of administration and distribution channel Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Women's health market value, 2024 (USD billion)
• Fig. 13 Market trends & outlook
• Fig. 14 Porter's five force analysis
• Fig. 15 PESTEL analysis
• Fig. 16 Endometriosis treatment market: Treatment type outlook and key takeaways
• Fig. 17 Endometriosis treatment market: Treatment type movement analysis
• Fig. 18 Pain medication market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Hormone therapy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Endometriosis treatment market: Drug class outlook and key takeaways
• Fig. 21 Endometriosis treatment market: Drug class movement analysis
• Fig. 22 NSAIDs market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Oral contraceptives market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Gonadotropin-releasing hormone market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Endometriosis treatment market: Route of administration outlook and key takeaways
• Fig. 27 Endometriosis treatment market: Route of administration movement analysis
• Fig. 28 Oral market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Injectable market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Endometriosis treatment market: Distribution channel outlook and key takeaways
• Fig. 32 Endometriosis treatment market: Distribution channel movement analysis
• Fig. 33 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Endometriosis treatment market revenue, by region, 2024 & 2030 (USD Million)
• Fig. 37 Regional marketplace: Key takeaways
• Fig. 38 North America endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Key country dynamics
• Fig. 40 U.S. endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Prevalence of endometriosis in the U.S. (2021 - 2030) in Million
• Fig. 42 Key country dynamics
• Fig. 43 Canada endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Prevalence of endometriosis in the Canada. (2021 - 2030) in Million
• Fig. 45 Key country dynamics
• Fig. 46 Mexico endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Prevalence of endometriosis in the Mexico. (2021 - 2030) in Million
• Fig. 48 Europe endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 UK endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Prevalence of endometriosis in the UK. (2021 - 2030) in Million
• Fig. 52 Key country dynamics
• Fig. 53 Germany endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Prevalence of endometriosis in the Germany. (2021 - 2030) in Million
• Fig. 55 Key country dynamics
• Fig. 56 France endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Prevalence of endometriosis in the France. (2021 - 2030) in Million
• Fig. 58 Key country dynamics
• Fig. 59 Italy endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Prevalence of endometriosis in the Italy. (2021 - 2030) in Million
• Fig. 61 Key country dynamics
• Fig. 62 Spain endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Prevalence of endometriosis in the Spain. (2021 - 2030) in Million
• Fig. 64 Key country dynamics
• Fig. 65 Denmark endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Prevalence of endometriosis in the Denmark. (2021 - 2030) in Million
• Fig. 67 Key country dynamics
• Fig. 68 Sweden endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Prevalence of endometriosis in the Sweden. (2021 - 2030) in Million
• Fig. 70 Key country dynamics
• Fig. 71 Norway endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Prevalence of endometriosis in the Norway. (2021 - 2030) in Million
• Fig. 73 Rest of Europe endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Asia Pacific endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 Japan endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 Prevalence of endometriosis in the Japan. (2021 - 2030) in Million
• Fig. 78 Key country dynamics
• Fig. 79 China endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 Prevalence of endometriosis in the China. (2021 - 2030) in Million
• Fig. 81 Key country dynamics
• Fig. 82 India endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Prevalence of endometriosis in the India. (2021 - 2030) in Million
• Fig. 84 Key country dynamics
• Fig. 85 Australia endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 86 Prevalence of endometriosis in the Australia. (2021 - 2030) in Million
• Fig. 87 Key country dynamics
• Fig. 88 Thailand endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 89 Prevalence of endometriosis in the Thailand. (2021 - 2030) in Million
• Fig. 90 Key country dynamics
• Fig. 91 South Korea endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 92 Prevalence of endometriosis in the South Korea. (2021 - 2030) in Million
• Fig. 93 Rest of Asia Pacific endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 94 Latin America endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 95 Key country dynamics
• Fig. 96 Brazil endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 97 Prevalence of endometriosis in the Brazil. (2021 - 2030) in Million
• Fig. 98 Key country dynamics
• Fig. 99 Argentina endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 100 Prevalence of endometriosis in the Argentina. (2021 - 2030) in Million
• Fig. 101 Rest of Latin America endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 102 MEA endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 103 Key country dynamics
• Fig. 104 South Africa endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 105 Prevalence of endometriosis in the South Africa. (2021 - 2030) in Million
• Fig. 106 Key country dynamics
• Fig. 107 Saudi Arabia endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 108 Prevalence of endometriosis in the Saudi Arabia. (2021 - 2030) in Million
• Fig. 109 Key country dynamics
• Fig. 110 UAE endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 111 Prevalence of endometriosis in the UAE. (2021 - 2030) in Million
• Fig. 112 Key country dynamics
• Fig. 113 Kuwait endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 114 Prevalence of endometriosis in the Kuwait. (2021 - 2030) in Million
• Fig. 115 Rest of MEA endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 116 Company/competition categorization
• Fig. 117 Company market position analysis, 2024
• Fig. 118 Strategy mapping

Endometriosis Treatment Market Growth & Trends:

The global endometriosis treatment market size is expected to reach USD 3.52 billion by 2030, registering a CAGR of 12.25% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributed to the presence of a late-stage robust product pipeline, the global upsurge in cases, and several initiatives undertaken by the government and key players at national and international levels to raise disease awareness.

The growing research and development for new treatment options in space is expected to offer a lucrative opportunity for market growth in the coming years. The launch of Myovant / Pfizer's Relugolix combination tablet, ObsEva's Yselty (linzagolix), and Ferring Pharmaceuticals / Novartis' Quinagolide are among prominent drug launches in this space that are anticipated to fuel the market growth.

Rising demand for endometriosis treatment is attributed to increasing disease burden and delay in diagnosis, worsening the disease condition. In March 2021, as per WHO, approximately 10% of female reproductive population is affected by the disease worldwide. According to the article, "Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs", a delay of three or more years in diagnosis from developing first symptom leads to increase in symptom burden and increase in healthcare cost by 50% compared with patients who were diagnosed earlier after symptom onset.

WHO, national governments, and private organizations are strategically involved in spreading awareness and educating people about endometriosis and its treatment, thereby supporting market growth. For instance, in March 2022, the Endometriosis Foundation of America hosted four weekends of the virtual program featuring patients and physicians, helping to connect endometriosis warriors and share their experiences with the disease. Moreover, in March 2022, Endometriosis U.K. also launched an eight-point action plan during the 'Endometriosis Action Month'.

Furthermore, key players are undertaking strategic initiatives such as mergers and acquisitions, collaborations, financial investments, and geographical expansion fueling the endometriosis treatment market. For instance, in November 2021, Organon and Co. announced to acquire Forendo Pharma, which will support Forendo's development of novel drugs in endometriosis like OR-6219, a phase 2 clinical candidate.

Endometriosis Treatment Market Report Highlights:

• By treatment type, the hormone therapy segment accounted for the largest share of the market in 2024 due to the high prescription rate of these drugs by physicians
• Gonadotropin-releasing hormone (GnRH) segment dominated the drug class segment in 2024 due to the high efficacy of GnRH agonists and GnRH antagonists and the increased availability of these products in the market
• In 2024, oral segment dominated the market with a 48.46% share by route of administration. It is the most common & convenient route of delivery for the majority of products in this space
• In 2024, retail pharmacy segment dominated the market by distribution channel. Moreover, hospital pharmacy is expected to demonstrate moderate growth
• North America dominated the global market in 2024 owing to increased disease incidence and high awareness among people and healthcare professionals about the condition therapies

Table of Content

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation
  • 1.1.1 Regional Scope
• 1.2 Market Definitions
  • 1.2.1 Estimates And Forecast Timeline
• 1.3 Objectives
  • 1.3.1 Objective - 1
  • 1.3.2 Objective - 2
  • 1.3.3 Objective - 3
• 1.4 Research Methodology
• 1.5 Information Procurement
  • 1.5.1 Purchased Database
  • 1.5.2 Gvr's Internal Database
  • 1.5.3 Secondary Sources
  • 1.5.4 Primary Research
  • 1.5.5 Details Of Primary Research
• 1.6 Information or Data Analysis
  • 1.6.1 Data Analysis Models
• 1.7 Market Formulation & Validation
• 1.8 Model Details
  • 1.8.1 Commodity Flow Analysis
    • 1.8.1.1 Approach 1: Commodity Flow Approach
    • 1.8.1.2 Approach 2: Country wise market estimation using bottom-up approach
• 1.9 List of Secondary Sources
• 1.10 List of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Treatment Type and Drug Class Segment Snapshot
• 2.3 Route of Administration and Distribution Channel Segment Snapshots
• 2.4 Competitive Landscape Snapshot

Chapter 3 Market Variables and Trends

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Related/Ancillary Market Outlook
• 3.2 Market Trends & Outlook
• 3.3 Market Dynamics
  • 3.3.1 Market Driver Analysis
    • 3.3.1.1 Rising disease burden
    • 3.3.1.2 Growing awareness toward the disease
    • 3.3.1.3 Increasing funding for research and development
  • 3.3.2 Market Restraint Analysis
    • 3.3.2.1 Availability of over the counter and generic drugs
• 3.4 Business Environment Analysis
  • 3.4.1 PORTER'S Five Forces Analysis
  • 3.4.2 PESTEL Analysis
• 3.5 Pipeline Analysis (Phase 3)

Chapter 4 Endometriosis Treatment Market- Segment Analysis, by Treatment Type, 2018 - 2030 (USD Million)

• 4.1 Endometriosis Treatment Market: Treatment Type Movement Analysis
• 4.2 Endometriosis Treatment Market Estimates & Forecast, By Treatment Type (USD Million)
  • 4.2.1 Pain Medication
  • 4.2.2 Hormone Therapy

Chapter 5 Endometriosis Treatment Market- Segment Analysis, by Drug Class, 2018 - 2030 (USD Million)

• 5.1 Endometriosis Treatment Market: Drug Class Movement Analysis
• 5.2 Endometriosis Treatment Market Estimates & Forecast, By Drug Class (USD Million)
  • 5.2.1 Nsaids
  • 5.2.2 Oral Contraceptives
  • 5.2.3 Gonadotropin-Releasing Hormone
  • 5.2.4 Others

Chapter 6 Endometriosis Treatment Market- Segment Analysis, by Route of Administration, 2018 - 2030 (USD Million)

• 6.1 Endometriosis Treatment Market: Route of Administration Movement Analysis
• 6.2 Endometriosis Treatment Market Estimates & Forecast, By Route of Administration (USD Million)
  • 6.2.1 Oral
  • 6.2.2 Injectable
  • 6.2.3 Others

Chapter 7 Endometriosis Treatment Market- Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

• 7.1 Endometriosis Treatment Market: Distribution Channel Movement Analysis
• 7.2 Endometriosis Treatment Market Estimates & Forecast, By Distribution Channel (USD Million)
  • 7.2.1 Hospital Pharmacies
  • 7.2.2 Retail Pharmacies
  • 7.2.3 Others

Chapter 8 Endometriosis Treatment Market: Regional Estimates and Trend Analysis by Type, Drug Class, Route of Administration, and Distribution Channel

• 8.1 Endometriosis Treatment Market: Regional Outlook
• 8.2 North America
  • 8.2.1 North America Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2 U.S.
    • 8.2.2.1 Key Country Dynamics
    • 8.2.2.2 U.S. Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2.3 Competitive/Market Scenario
    • 8.2.2.4 Regulatory Framework
    • 8.2.2.5 Reimbursement Scenario
  • 8.2.3 Canada
    • 8.2.3.1 Key Country Dynamics
    • 8.2.3.2 Canada Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3.3 Competitive/Market Scenario
    • 8.2.3.4 Regulatory Framework
    • 8.2.3.5 Reimbursement Scenario
  • 8.2.4 Mexico
    • 8.2.4.1 Key Country Dynamics
    • 8.2.4.2 Mexico Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4.3 Competitive/Market Scenario
    • 8.2.4.4 Regulatory Framework
    • 8.2.4.5 Reimbursement Scenario
• 8.3 Europe
  • 8.3.1 Europe Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2 UK
    • 8.3.2.1 Key Country Dynamics
    • 8.3.2.2 UK Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2.3 Competitive/Market Scenario
    • 8.3.2.4 Regulatory Framework
    • 8.3.2.5 Reimbursement Scenario
  • 8.3.3 Germany
    • 8.3.3.1 Key Country Dynamics
    • 8.3.3.2 Germany Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3.3 Competitive/Market Scenario
    • 8.3.3.4 Regulatory Framework
    • 8.3.3.5 Reimbursement Scenario
  • 8.3.4 France
    • 8.3.4.1 Key Country Dynamics
    • 8.3.4.2 France Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4.3 Competitive/Market Scenario
    • 8.3.4.4 Regulatory Framework
    • 8.3.4.5 Reimbursement Scenario
  • 8.3.5 Italy
    • 8.3.5.1 Key Country Dynamics
    • 8.3.5.2 Italy Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5.3 Competitive/Market Scenario
    • 8.3.5.4 Regulatory Framework
    • 8.3.5.5 Reimbursement Scenario
  • 8.3.6 Spain
    • 8.3.6.1 Key Country Dynamics
    • 8.3.6.2 Spain Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6.3 Competitive/Market Scenario
    • 8.3.6.4 Regulatory Framework
    • 8.3.6.5 Reimbursement Scenario
  • 8.3.7 Denmark
    • 8.3.7.1 Key Country Dynamics
    • 8.3.7.2 Denmark Influenza Vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.7.3 Competitive/Market Scenario
    • 8.3.7.4 Regulatory Framework
    • 8.3.7.5 Reimbursement Scenario
  • 8.3.8 Sweden
    • 8.3.8.1 Key Country Dynamics
    • 8.3.8.2 Sweden Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8.3 Competitive/Market Scenario
    • 8.3.8.4 Regulatory Framework
    • 8.3.8.5 Reimbursement Scenario
  • 8.3.9 Norway
    • 8.3.9.1 Key Country Dynamics
    • 8.3.9.2 Norway Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9.3 Competitive/Market Scenario
    • 8.3.9.4 Regulatory Framework
    • 8.3.9.5 Reimbursement Scenario
  • 8.3.10 Rest Of Europe Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.4 Asia Pacific
  • 8.4.1 Asia Pacific Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2 Japan
    • 8.4.2.1 Key Country Dynamics
    • 8.4.2.2 Japan Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2.3 Competitive/Market Scenario
    • 8.4.2.4 Regulatory Framework
    • 8.4.2.5 Reimbursement Scenario
  • 8.4.3 China
    • 8.4.3.1 Key Country Dynamics
    • 8.4.3.2 China Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3.3 Competitive/Market Scenario
    • 8.4.3.4 Regulatory Framework
    • 8.4.3.5 Reimbursement Scenario
  • 8.4.4 India
    • 8.4.4.1 Key Country Dynamics
    • 8.4.4.2 India Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4.3 Competitive/Market Scenario
    • 8.4.4.4 Regulatory Framework
    • 8.4.4.5 Reimbursement Scenario
  • 8.4.5 Australia
    • 8.4.5.1 Key Country Dynamics
    • 8.4.5.2 Australia Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5.3 Competitive/Market Scenario
    • 8.4.5.4 Regulatory Framework
    • 8.4.5.5 Reimbursement Scenario
  • 8.4.6 Thailand
    • 8.4.6.1 Key Country Dynamics
    • 8.4.6.2 Thailand Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6.3 Competitive/Market Scenario
    • 8.4.6.4 Regulatory Framework
    • 8.4.6.5 Reimbursement Scenario
  • 8.4.7 South Korea
    • 8.4.7.1 Key Country Dynamics
    • 8.4.7.2 South Korea Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7.3 Competitive/Market Scenario
    • 8.4.7.4 Regulatory Framework
    • 8.4.7.5 Reimbursement Scenario
  • 8.4.8 Rest Of Asia Pacific Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5 Latin America
  • 8.5.1 Latin America Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2 Brazil
    • 8.5.2.1 Key Country Dynamics
    • 8.5.2.2 Brazil Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2.3 Competitive/Market Scenario
    • 8.5.2.4 Regulatory Framework
    • 8.5.2.5 Reimbursement Scenario
  • 8.5.3 Argentina
    • 8.5.3.1 Key Country Dynamics
    • 8.5.3.2 Argentina Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3.3 Competitive/Market Scenario
    • 8.5.3.4 Regulatory Framework
    • 8.5.3.5 Reimbursement Scenario
  • 8.5.4 Rest Of Latin America Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6 Middle East & Africa (MEA)
  • 8.6.1 Mea Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2 South Africa
    • 8.6.2.1 Key Country Dynamics
    • 8.6.2.2 South Africa Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2.3 Competitive/Market Scenario
    • 8.6.2.4 Regulatory Framework
    • 8.6.2.5 Reimbursement Scenario
  • 8.6.3 Saudi Arabia
    • 8.6.3.1 Key Country Dynamics
    • 8.6.3.2 Saudi Arabia Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3.3 Competitive/Market Scenario
    • 8.6.3.4 Regulatory Framework
    • 8.6.3.5 Reimbursement Scenario
  • 8.6.4 UAE
    • 8.6.4.1 Key Country Dynamics
    • 8.6.4.2 UAE Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4.3 Competitive/Market Scenario
    • 8.6.4.4 Regulatory Framework
    • 8.6.4.5 Reimbursement Scenario
  • 8.6.5 Kuwait
    • 8.6.5.1 Key Country Dynamics
    • 8.6.5.2 Kuwait Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5.3 Competitive/Market Scenario
    • 8.6.5.4 Regulatory Framework
    • 8.6.5.5 Reimbursement Scenario
  • 8.6.6. Rest of MEA Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

• 9.1 Participant Categorization
• 9.2 Participants' Overviews
• 9.3 Financial Performance
• 9.4 Product Benchmarking
• 9.5 Company Market Position Analysis
• 9.6 Company Profiles
  • 9.6.1 Bayer AG
    • 9.6.1.1 Company Overview
    • 9.6.1.2 Financial Performance
    • 9.6.1.3 Product Benchmarking
    • 9.6.1.4 Strategic Initiatives
  • 9.6.2 Pfizer, Inc.
    • 9.6.2.1 Company Overview
    • 9.6.2.2 Financial Performance
    • 9.6.2.3 Product Benchmarking
    • 9.6.2.4 Strategic Initiatives
  • 9.6.3 AbbVie, Inc
    • 9.6.3.1 Company Overview
    • 9.6.3.2 Financial Performance
    • 9.6.3.3 Product Benchmarking
    • 9.6.3.4 Strategic Initiatives
  • 9.6.4 AstraZeneca
    • 9.6.4.1 Company Overview
    • 9.6.4.2 Financial Performance
    • 9.6.4.3 Product Benchmarking
    • 9.6.4.4 Strategic Initiatives
  • 9.6.5 ObsEva SA
    • 9.6.5.1 Company Overview
    • 9.6.5.2 Financial Performance
    • 9.6.5.3 Product Benchmarking
    • 9.6.5.4 Strategic Initiatives
  • 9.6.6 Teva Pharmaceutical Industries Ltd.
    • 9.6.6.1 Company Overview
    • 9.6.6.2 Financial Performance
    • 9.6.6.3 Product Benchmarking
    • 9.6.6.4 Strategic Initiatives
  • 9.6.7 Teva Pharmaceutical Industries Ltd.
    • 9.6.7.1 Company Overview
    • 9.6.7.2 Financial performance
    • 9.6.7.3 Product Benchmarking
    • 9.6.7.4 Strategic Initiatives
  • 9.6.8 ELI LILLY AND COMPANY
    • 9.6.8.1 Company Overview
    • 9.6.8.2 Financial performance
    • 9.6.8.3 Product Benchmarking
    • 9.6.8.4 Strategic Initiatives
  • 9.6.9 Astellas Pharma, Inc.
    • 9.6.9.1 Company Overview
    • 9.6.9.2 Financial performance
    • 9.6.9.3 Product Benchmarking
    • 9.6.9.4 Strategic Initiatives
• 9.7 Strategy Mapping
  • 9.7.1 New Product Launches
  • 9.7.2 Acquisition
  • 9.7.3 Collaborations
  • 9.7.4 Partnerships
  • 9.7.5 Others (Clinical Trials, Campaign, Legal, And Pricing)

Chapter 10 Conclusion